BIOSYNTHESIS OF TAXOL AND RELATED COMPOUNDS

紫杉醇及相关化合物的生物合成

基本信息

  • 批准号:
    2106991
  • 负责人:
  • 金额:
    $ 22.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-08-05 至 1999-04-30
  • 项目状态:
    已结题

项目摘要

Taxol, a diterpene derivative isolated from Taxus brevifolia and other Taxus species, is an important new anti-cancer agent. It has been approved by the FDA for treatment of ovarian cancer and also shows promise against breast, lung and other cancers. Taxotere, a semisynthetic analog, is also undergoing clinical evaluation with, so far, excellent results. These clinical successes have raised the problem of securing adequate commercial supplies of these drugs. The complexity of the structures does not bode well for an economically viable total synthesis of these drugs, and even after the imminent replacement of new bark extraction by semisynthesis from a more abundant taxane, 10-deacetylbaccatin-III, as the commercial source of taxol, the supply of these and future generation taxane-based drugs will depend on biosynthesis of at least the functionalized taxane ring system for years to come. It is the long-term goal of this project to elucidate, at the chemical, enzymatic and eventually, genetic level, the biosynthetic pathway by which taxol and related taxanes are assembled in the yew plant. We propose to (1) establish the mode of formation of the taxane ring system from its presumed precursor, geranylgeranyl pyrophosphate, (2) map the sequence of reactions leading from the initial hydrocarbon precursor to the fully functionalized taxane moiety of taxol, (3) gain mechanistic insight into the transformation of phenylalanine into the phenylisoserine and benzoate moieties of taxol and (4) confirm the model and stage of attachment of the C-13 side chain to the ring system and isolate the enzyme(s) catalyzing this process. As a tool for these studies we will also develop and optimize Taxus cell cultures to levels of taxane production useful for biosynthetic experiments. It is anticipated that the information generated will help provide the knowledge base for efforts to develop alternative biotechnological processes for the commercial production of these important new antitumor drugs.
紫杉醇,从短叶红豆杉和其它植物中分离得到的二萜衍生物

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HEINZ G FLOSS其他文献

HEINZ G FLOSS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HEINZ G FLOSS', 18)}}的其他基金

DEOXYHEXOSE BIOSYNTHESIS
脱氧己糖生物合成
  • 批准号:
    6387080
  • 财政年份:
    2000
  • 资助金额:
    $ 22.58万
  • 项目类别:
DEOXYHEXOSE BIOSYNTHESIS
脱氧己糖生物合成
  • 批准号:
    6194393
  • 财政年份:
    2000
  • 资助金额:
    $ 22.58万
  • 项目类别:
DEOXYHEXOSE BIOSYNTHESIS
脱氧己糖生物合成
  • 批准号:
    6520166
  • 财政年份:
    2000
  • 资助金额:
    $ 22.58万
  • 项目类别:
NEW PATHWAY OF ISOPRENOID BIOSYNTHESIS
类异戊二烯生物合成的新途径
  • 批准号:
    6309041
  • 财政年份:
    2000
  • 资助金额:
    $ 22.58万
  • 项目类别:
NEW PATHWAY OF ISOPRENOID BIOSYNTHESIS
类异戊二烯生物合成的新途径
  • 批准号:
    6120833
  • 财政年份:
    1999
  • 资助金额:
    $ 22.58万
  • 项目类别:
NEW PATHWAY OF ISOPRENOID BIOSYNTHESIS
类异戊二烯生物合成的新途径
  • 批准号:
    6281458
  • 财政年份:
    1998
  • 资助金额:
    $ 22.58万
  • 项目类别:
BIOSYNTHESIS OF MAYTANSINOIDS AND ANALOGS
美登素及其类似物的生物合成
  • 批准号:
    6124450
  • 财政年份:
    1998
  • 资助金额:
    $ 22.58万
  • 项目类别:
BIOSYNTHESIS OF MAYTANSINOIDS AND ANALOGS
美登素及其类似物的生物合成
  • 批准号:
    6329018
  • 财政年份:
    1998
  • 资助金额:
    $ 22.58万
  • 项目类别:
Biosynthesis of Maytansinoids and Analogs
美登木素生物碱及其类似物的生物合成
  • 批准号:
    6545627
  • 财政年份:
    1998
  • 资助金额:
    $ 22.58万
  • 项目类别:
BIOSYNTHESIS OF MAYTANSINOIDS AND ANALOGS
美登素及其类似物的生物合成
  • 批准号:
    2837787
  • 财政年份:
    1998
  • 资助金额:
    $ 22.58万
  • 项目类别:

相似海外基金

CAREER: Using Microbial Bioproduction Platform to Elucidate Phytochemical Biosynthesis - Strigolactone as An Example
职业:利用微生物生物生产平台阐明植物化学生物合成——以独脚金内酯为例
  • 批准号:
    2420331
  • 财政年份:
    2024
  • 资助金额:
    $ 22.58万
  • 项目类别:
    Continuing Grant
Decoding functional glycan biosynthesis
解码功能性聚糖生物合成
  • 批准号:
    BB/Y000102/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.58万
  • 项目类别:
    Research Grant
Investigating biosynthesis of the newly discovered natural product euglenatide and distribution across the breadth of Euglenoid algae
研究新发现的天然产物眼虫肽的生物合成及其在眼虫类藻类中的分布
  • 批准号:
    EP/Y003314/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.58万
  • 项目类别:
    Research Grant
Discovery and reconstitution of securinine alkaloid biosynthesis
叶秋碱生物碱生物合成的发现和重建
  • 批准号:
    BB/Y003586/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.58万
  • 项目类别:
    Research Grant
RUI: BIOPOLYMER - BIObricks POLYketide Metabolic EngineeRing platform for unraveling the biosynthesis of higher anthracyclines
RUI:BIOPOLYMER - BIObricks 聚酮化合物代谢工程平台,用于揭示高级蒽环类药物的生物合成
  • 批准号:
    2321976
  • 财政年份:
    2024
  • 资助金额:
    $ 22.58万
  • 项目类别:
    Standard Grant
Cross talk between DNA replication and LPS biosynthesis during cell growth
细胞生长过程中 DNA 复制和 LPS 生物合成之间的串扰
  • 批准号:
    BB/Y001265/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.58万
  • 项目类别:
    Research Grant
Molecular mechanisms of Pel biosynthesis
Pel生物合成的分子机制
  • 批准号:
    489549
  • 财政年份:
    2023
  • 资助金额:
    $ 22.58万
  • 项目类别:
    Operating Grants
The role of cholesterol biosynthesis in CAF for tumorigenesis
CAF 中胆固醇生物合成对肿瘤发生的作用
  • 批准号:
    23K14585
  • 财政年份:
    2023
  • 资助金额:
    $ 22.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
  • 批准号:
    2884862
  • 财政年份:
    2023
  • 资助金额:
    $ 22.58万
  • 项目类别:
    Studentship
Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
  • 批准号:
    10653587
  • 财政年份:
    2023
  • 资助金额:
    $ 22.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了